Cancer drugs in short supply

In recent months, multiple cancer drugs have been in short supply in the United States. While the Food and Drug Administration and the

cancer patients in the US are receiving devastating news: the critical drugs that may be needed to treat their cancer are in short supply.

In recent months, drug shortages have become more pronounced. Some of the drugs in short supply are critical for the treatment of cancer

There is a shortage of cancer drugs in the United States. As of May 2024, the FDA listed 17 commonly used cancer fighting drugs that are in short supply.

Pluvicto is among a handful of cancer drugs in short supply in the U.S. BCG, a drug for bladder cancer; and methotrexate and cisplatin, two common chemotherapy drugs, are also in shortage

According to the survey, 89 percent of the 28 cancer centers surveyed reported that cancer drugs are in short supply, most often vinblastine (57

Adderall, Ozempic, albuterol, antibiotics and lifesaving cancer meds are in short supply Demand for diabetes drugs Ozempic and Wegovy

Pluvicto, a drug used to treat advanced prostate cancer, is in short supply, the Food and Drug Administration reported last week.

In recent months, multiple cancer drugs have been in short supply in the United States. While the Food and Drug Administration and the